Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study (Q35166512)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study |
scientific article |
Statements
1 reference
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study (English)
1 reference
Casper G Schalkwijk
1 reference
Stijn A Peeters
1 reference
Lian Engelen
1 reference
Jacqueline Buijs
1 reference
Nish Chaturvedi
1 reference
John H Fuller
1 reference
Coen D Stehouwer
1 reference
EURODIAB Prospective Complications Study Group
1 reference
10 March 2015
1 reference
1 reference
10 March 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference